Molecular Cytogenetics Market Overview 2024-2033 – Competitive Landscape and Strategies

The Molecular Cytogenetics Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

Learn More On The Molecular Cytogenetics Market:
https://www.thebusinessresearchcompany.com/report/molecular-cytogenetics-global-market-report

According to The Business Research Company’s Molecular Cytogenetics Global Market Report 2024, The molecular cytogenetics market size has grown rapidly in recent years. It will grow from $2.65 billion in 2023 to $2.93 billion in 2024 at a compound annual growth rate (CAGR) of 10.4%. The  growth in the historic period can be attributed to rise in genetic disorders and cancer cases, growing demand for personalized medicine, research and development in life sciences, clinical applications for prenatal and postnatal diagnosis, global initiatives in genomic medicine.

The molecular cytogenetics market size is expected to see strong growth in the next few years. It will grow to $4.24 billion in 2028 at a compound annual growth rate (CAGR) of 9.7%. The growth in the forecast period can be attributed to emergence of next-generation sequencing (ngs), increased focus on liquid biopsies, growing application in cancer research, expanding applications in infectious disease diagnosis, rapid growth in genetic testing services. Major trends in the forecast period include next-generation sequencing (ngs) in cytogenetic, automation and high-throughput screening, fluorescence in situ hybridization (fish) advancements, rising application in cancer diagnostics, single-cell analysis.

The increasing incidence of genetic disorders and cancer is expected to drive the growth of the molecular cytogenetics market going forward. Cancer refers to a disease in which the body’s cells grow uncontrollably and spread to other parts of the body. Cytogenetics testing samples of tissue and blood are used for changes in chromosomes, such as broken, missing, or rearranged chromosomes. Changes in certain chromosomes are a sign of a genetic disease, condition, or some types of cancer. Hence, the increasing incidence of genetic disorders and cancer will propel the growth of the market. For instance, according to the American Cancer Society, a US-based nationwide voluntary health organization, by 2040, the global burden is expected to grow to 27.5 million new cancer cases and 16.3 million cancer deaths. Additionally, in 2022, 1,918,030 new cancer cases and 609,360 cancer deaths occurred in the United States, including approximately 350 deaths per day from lung cancer. Therefore, the increasing incidence of genetic disorders and cancer is driving the growth of the molecular cytogenetics market.

Get A Free Sample Of The Report (Includes Graphs And Tables):
https://www.thebusinessresearchcompany.com/sample.aspx?id=10096&type=smp

The molecular cytogenetics market covered in this report is segmented –

1) By Product: Instruments, Kits And Reagents, Software, Services, Consumables Or Accessories
2) By Technology: Comparative Genomic Hybridization, Fluorescence In Situ Hybridization, Immunohistochemistry, Karyotyping, Other Technologies
3) By Application: Genetic Disorders, Cancer, Personalized Medicines, Other Applications
4) By End-User: Clinical And Research Laboratories, Academic Research Institutes, Pharmaceutical, Biotechnology Companies, Other End-Users

Product innovations are a key trend gaining popularity in the molecular cytogenetics market. Major Companies operating in the molecular cytogenetics market are adopting new technologies to strengthen their position in the market. For example, in March 2021, Agilent Technologies Inc, a US-based company that provides instruments, software, services, and consumables for laboratories launched three new microarrays for the needs of cytogenetic laboratories for both prenatal and postnatal research. The Agilent GenetiSure Cyto microarrays have updated, clinically relevant content from the databases. It would provide high-resolution detection of copy number variations, and copy-neutral loss of heterozygosity that have been associated with developmental delay, neuropsychiatric disorders, intellectual disability, and congenital anomalies in constitutional DNA samples.

The molecular cytogenetics market report table of contents includes:

1. Executive Summary
2. Market Characteristics
3. Market Trends And Strategies
4. Impact Of COVID-19
5. Market Size And Growth
6. Segmentation
7. Regional And Country Analysis
.
.
.
27. Competitive Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293

Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model